Home » Topics » Disease categories and therapies » Cardiovascular

Cardiovascular
RSS

Endovasc reports positive drug delivery findings

Dec. 10, 2004

Low-dose PW-2101 fails to meet primary endpoint in pivotal hypertension study

Dec. 7, 2004

EP-2306 and EP-2302 effectively inhibit LDL oxidation, possible application in atherosclerosis

Dec. 7, 2004

Citrus bioflavonoid naringin and lovastatin show comparable hypocholesterolemic effects in vivo

Dec. 7, 2004

Tumor necrosis factor inhibitor may attenuate postmyocardial infarction ventricular remodeling

Dec. 3, 2004

Iroxanadine shows promise for cardiovascular disease in mouse study

Dec. 3, 2004

Diovan approved in Sweden to treat high-risk heart attack patients

Dec. 3, 2004

Cilnidipine for the treatment of arrhythmia

Dec. 2, 2004

Myogen completes two pivotal clinical trials on enoximone in CHF

Dec. 2, 2004

Cardiome selects oral controlled-release formulation of RSD-1235

Dec. 1, 2004

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 24, 2026.
To viral or not to viral: In vivo CAR T debates delivery tech
BioWorld
The field of cell and gene therapy is moving toward a new phase of scalability and clinical durability, with in vivo chimeric antigen receptor (CAR) T-cell...
News in brief
BioWorld Asia
BioWorld Asia briefs for July 21, 2026
KBN-2201 reverses key features of Alzheimer’s in mice
BioWorld Science
Researchers from Ajou University School of Medicine reported the preclinical efficacy of KBN-2201 in a mouse model of late-stage Alzheimer’s disease.
To viral or not to viral: In vivo CAR T debates delivery tech
BioWorld Science
The field of cell and gene therapy is moving toward a new phase of scalability and clinical durability, with in vivo chimeric antigen receptor (CAR) T-cell...